Sorry, you need to enable JavaScript to visit this website.

Plant bioengineering for the production of molecules of medical, veterinary, and agri-food interest

Production of antibodies in plants for the diagnosis and treatment of infectious and oncological diseases

The production of recombinant antibodies in plant systems has reached a high level of maturity, emerging as an effective and advantageous alternative to classical methods based on animal cell cultures. Key benefits include greater versatility in design and production, significantly reduced analysis times, lower costs, and improved reliability and robustness of analytical methods. Monoclonal antibodies specific for aflatoxins B1 and M1 have been isolated and produced in plants to develop “green” immunoassays for quantification in food matrices such as corn and milk.

Plant biofactories for the production of vaccines and diagnostic tools for the management of infectious and zoonotic diseases

Plant biofactories have proven to be a valuable platform for producing numerous antigens effective in the prevention and diagnosis of various infectious diseases, including in the veterinary field. In this context, vaccines represent a powerful prophylactic tool capable of limiting the global impact of zoonoses as well as contributing to the reduction of antimicrobial use, thereby counteracting the emergence of antibiotic resistance.